HELICOBACTER

Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing

Review of antimicrobial peptides with anti‐Helicobacter pylori activity

High‐dose PPI‐amoxicillin dual therapy with or without bismuth for first‐line Helicobacter pylori therapy: A randomized trial

The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults

Bismuth supplements as the first‐line regimen for Helicobacter pylori eradication therapy: Systemic review and meta‐analysis

Helicobacter pylori infection alters gastric and tongue coating microbial communities

Bismuth‐containing quadruple therapy versus concomitant quadruple therapy as first‐line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross‐sectional, comparative, open trial

Previous Helicobacter pylori infection–induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication

Review: Helicobacter pylori and extragastric diseases

Systematic review: Would susceptibility‐guided treatment achieve acceptable cure rates for second‐line Helicobacter pylori therapy as currently practiced?

Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018

Systematic review and meta‐analysis: Effect of Helicobacter pylori eradication on chronic spontaneous urticaria

Cost‐effectiveness analysis of screen‐and‐treat strategy in asymptomatic Chinese for preventing Helicobacter pylori‐associated diseases

Helicobacter pylori infection and prevalence of stroke

Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single‐center prospective pilot study

Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging

A lucid review of Helicobacter pylori‐induced DNA damage in gastric cancer

Helicobacter pylori eradication regimens in an antibiotic high‐resistance European area: A cost‐effectiveness analysis

Bismuth, rabeprazole, amoxicillin, and doxycycline as first‐line Helicobacter pylori therapy in clinical practice: A pilot study

Half‐dose clarithromycin‐containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single‐center, open‐label, randomized trial

Evolution of Helicobacter pylori associated with gastroduodenal ulcers or erosions in children over the past 23 years: Decline or steady state?

Effectiveness and safety of furazolidone‐containing quadruple regimens in patients with Helicobacter pylori infection in real‐world practice

Prevalence of Helicobacter pylori infection among junior high school students in Grudziadz, Poland

The relationship of gastric microbiota and Helicobacter pylori infection in pediatrics population

Once‐daily rabeprazole, levofloxacin, clarithromycin‐MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study)

The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systematic review and meta‐analysis

Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy.

Interleukin‐27 is abrogated in gastric cancer, but highly expressed in other Helicobacter pylori‐associated gastroduodenal diseases

Management of Helicobacter pylori infection by clinicians: A nationwide survey in a developing country

Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis with trial sequential analysis

Mucoid and coccoid Helicobacter pylori with fast growth and antibiotic resistance

High‐risk symptoms do not predict gastric cancer precursors

Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades

The prevalence of histologic atrophy and intestinal metaplasia in the corpus has decreased over 15 years in females in the Korean population

Spasmolytic polypeptide‐expressing metaplasia associated with higher expressions of miR‐21, 155, and 223 can be regressed by Helicobacter pylori eradication in the gastric cancer familial relatives

Extragastric diseases correlated with Helicobacter pylori

Helicobacter pylori heteroresistance to clarithromycin in adults—New data by in situ detection and improved concept

The most influential articles in Helicobacter pylori research: A bibliometric analysis

The clinical meaning of the “indefinite for atrophy” lesions within gastric mucosa biopsy specimens in a region with a high prevalence of gastric cancer

Combined effect between WT1 methylation and Helicobacter pylori infection, smoking, and alcohol consumption on the risk of gastric cancer

Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low‐resource Central America setting

Gastric juice‐based PCR assay: An alternative testing method to aid in the management of previously treated Helicobacter pylori infection

Molecular epidemiologic and clinical analysis of Helicobacter cinaedi bacteremia in Japan

Twice‐a‐day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori. Two randomized pilot studies

Detection of Helicobacter pylori with clarithromycin resistance‐associated mutations using peptide nucleic acid probe‐based melting point analysis

Low‐level primary clarithromycin resistance of Helicobacter pylori in Burkina Faso: A prospective molecular study

CHAC1 overexpression in human gastric parietal cells with Helicobacter pylori infection in the secretory canaliculi